This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
STMN1 · Western blot design guide
STMN1 Western Blot Planning Guide
Plan a STMN1 Western blot around the catalog-observed 17.3 kDa band, image-backed PB9560 evidence, HPA controls, and verified protocol records.
Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
STMN1 Western Blot Experimental Design Guide
Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | 17.3 kDa | |
| Observed band | Not reported — verify product WB image | |
| Gel | 15% | |
| Positive control | Colon | |
| Negative control | Bronchus |
Important caveats
Reasons your observed band may differ from the expected size.
| ⓘ | Calculated mass | 17.3 kDa |
| ⓘ | Localization | Cytoplasm, cytoskeleton |
| ⓘ | Processing / PTM | Record-dependent |
| ⓘ | Reactivity | Human / Mouse / Rat |
Section 1
Real Curated STMN1 Western Blot Protocols
Start with the molecular-weight rule, then compare verified publication-derived conditions.
| Sample / lysate | Bone marrow |
| Gel % | 15% |
| Load | 20-30 µg total protein per lane |
| Transfer | Semi-dry, short transfer |
| Membrane | 0.2 µm PVDF |
| Blocking | 5% non-fat milk or 5% BSA in TBST |
| Primary | PB9560 at datasheet starting dilution |
| Primary incubation | Overnight at 4 °C with gentle agitation |
| Secondary | Species-matched HRP conjugate at validated dilution |
| Wash | 3 × 5 min in TBST |
| Detection | Chemiluminescent substrate |
| Exposure | Bracket exposures to avoid saturation |
Section 2
What Is the Expected STMN1 Western Blot Band Size?
Use the product-observed 17.3 kDa band as the primary planning value and retain the UniProt calculated mass as context.
| 17.3 kDa | Matches the authoritative product WB observation. |
| 17.3 kDa calculated | Use as UniProt context, not as a replacement observed band. |
| Unexpected additional signal | Do not assign identity without orthogonal positive/negative controls. |
💡Expected STMN1 appearancePlan around 17.3 kDa and keep the calculated mass as supporting context.
| Catalog-observed band | 17.3 kDa; use this as the primary experimental expectation. |
| Calculated mass | 17.3 kDa from UniProt P16949; retain as context. |
| Gel selection | 15%; shared with the recommended protocol and poster. |
| Specificity check | Compare the lead HPA positive and negative controls with PB9560. |
| Situation | Likely cause | Next action |
|---|---|---|
| 17.3 kDa | Matches the authoritative product WB observation. | Confirm with orthogonal controls and the linked product record. |
| Additional band | May reflect processing, modification, or non-specific signal. | Run a dilution series and compare positive/negative controls. |
| Weak signal | Target abundance or transfer may be limiting. | Verify transfer, increase positive-control abundance, and bracket exposure. |
Experiment evidence
Western blot images showing STMN1 band
PB9560 · STMN1
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for STMN1 Western blot
🧪Use Colon as the first positive-control candidate and Bronchus as the HPA Not detected negative candidate.
Positive control: Colon (High)
Negative control: Bronchus (Not detected)
HPA protein score determines control status; other expression data is supporting context only.
HPA tissue expression evidence for STMN1
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Colon | Reported tissue cells | High | Protein (HPA) | HPA → |
| Bone marrow | Reported tissue cells | High | Protein (HPA) | HPA → |
| Duodenum | Reported tissue cells | High | Protein (HPA) | HPA → |
| Endometrium | Reported tissue cells | High | Protein (HPA) | HPA → |
Section 3
Advanced STMN1 Western Blot Tips
Deeper troubleshooting and optimisation questions for STMN1, answered from its protein features.
Which band should guide the blot?
Use 17.3 kDa, the observation attached to the authoritative PB9560 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 17.3 kDa expectation.
Which positive control should I start with?
Start with Colon, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Bronchus as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for STMN1 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should PB9560 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents
STMN1 Western Blot Reagents
Human/Mouse/Rat-reactive STMN1 Western blot reagents with authoritative product imagery.
Real WB data
Anti-Stathmin 1/STMN1 Antibody Picoband®
Cat # PB9560
Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.
Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.
References
- UniProt P16949
- Human Protein Atlas — STMN1
- PB9560 product record
- PMC10404615 — The Stathmin-2 membrane-targeting domain is required for axon protection and regulated degradation by DLK signaling (The Journal of biological chemistry, 2023)
- PMC11880488 — STMN1 regulates the stemness of gastric cancer cells by binding to HN1L to activate the STAT3 signaling pathway (Discover oncology, 2025)
- PMC13402353 — SEC14L2 couples chaperone-mediated autophagy to microtubule stability by targeting Stathmin 1 (Nature communications, 2026)
